Performance of current risk stratification models for predicting mortality in patients with heart failure: a systematic review and meta-analysis
- PMID: 35919956
- DOI: 10.1093/eurjpc/zwac148
Performance of current risk stratification models for predicting mortality in patients with heart failure: a systematic review and meta-analysis
Abstract
Aims: There are several risk scores designed to predict mortality in patients with heart failure (HF). This study aimed to assess performance of risk scores validated for mortality prediction in patients with acute HF (AHF) and chronic HF.
Methods and results: MEDLINE and Scopus were searched from January 2015 to January 2021 for studies which internally or externally validated risk models for predicting all-cause mortality in patients with AHF and chronic HF. Discrimination data were analysed using C-statistics, and pooled using generic inverse-variance random-effects model. Nineteen studies (n = 494 156 patients; AHF: 24 762; chronic HF mid-term mortality: 62 000; chronic HF long-term mortality: 452 097) and 11 risk scores were included. Overall, discrimination of risk scores was good across the three subgroups: AHF mortality [C-statistic: 0.76 (0.68-0.83)], chronic HF mid-term mortality [1 year; C-statistic: 0.74 (0.68-0.79)], and chronic HF long-term mortality [≥2 years; C-statistic: 0.71 (0.69-0.73)]. MEESSI-AHF [C-statistic: 0.81 (0.80-0.83)] and MARKER-HF [C-statistic: 0.85 (0.80-0.89)] had an excellent discrimination for AHF and chronic HF mid-term mortality, respectively, whereas MECKI had good discrimination [C-statistic: 0.78 (0.73-0.83)] for chronic HF long-term mortality relative to other models. Overall, risk scores predicting short-term mortality in patients with AHF did not have evidence of poor calibration (Hosmer-Lemeshow P > 0.05). However, risk models predicting mid-term and long-term mortality in patients with chronic HF varied in calibration performance.
Conclusions: The majority of recently validated risk scores showed good discrimination for mortality in patients with HF. MEESSI-AHF demonstrated excellent discrimination in patients with AHF, and MARKER-HF and MECKI displayed an excellent discrimination in patients with chronic HF. However, modest reporting of calibration and lack of head-to-head comparisons in same populations warrant future studies.
Keywords: heart failure; mortality; risk prediction; risk score; risk stratification model.
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest: S.J.G. has received research support from the Duke University Department of Medicine Chair’s Research Award, American Heart Association, Amgen, AstraZeneca, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Pfizer, and Sanofi; has served on advisory boards for Amgen, AstraZeneca, Bristol Myers Squibb, Cytokinetics, Roche Diagnostics, and Sanofi; and serves as a consultant for Amgen, Bayer, Bristol Myers Squibb, Merck, Sanofi, and Vifor. H.G.C.V.S. receives research support from the Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.
Comment in
-
Risk stratification models for predicting mortality in heart failure: a favourite or an outsider?Eur J Prev Cardiol. 2024 Jan 25;31(2):272-273. doi: 10.1093/eurjpc/zwac173. Eur J Prev Cardiol. 2024. PMID: 35950368 No abstract available.
Similar articles
-
Validation of the Get With The Guideline-Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level.Am Heart J. 2016 Jan;171(1):33-9. doi: 10.1016/j.ahj.2015.10.008. Epub 2015 Nov 11. Am Heart J. 2016. PMID: 26699598
-
External Validation of the MEESSI Acute Heart Failure Risk Score: A Cohort Study.Ann Intern Med. 2019 Feb 19;170(4):248-256. doi: 10.7326/M18-1967. Epub 2019 Jan 29. Ann Intern Med. 2019. PMID: 30690646
-
Incremental value of C-reactive protein to the MEESSI acute heart failure risk score.Eur J Heart Fail. 2024 Aug;26(8):1749-1758. doi: 10.1002/ejhf.3349. Epub 2024 Jun 23. Eur J Heart Fail. 2024. PMID: 38923253
-
Prognostic models for heart failure in patients with type 2 diabetes: a systematic review and meta-analysis.Heart. 2023 Sep 13;109(19):1436-1442. doi: 10.1136/heartjnl-2022-322044. Heart. 2023. PMID: 36898704
-
Systematic review and meta-analysis of current risk models in predicting short-term mortality after transcatheter aortic valve replacement.EuroIntervention. 2020 Apr 17;15(17):1497-1505. doi: 10.4244/EIJ-D-19-00636. EuroIntervention. 2020. PMID: 31659984
Cited by
-
Development of interpretable machine learning models to predict in-hospital prognosis of acute heart failure patients.ESC Heart Fail. 2024 Oct;11(5):2798-2812. doi: 10.1002/ehf2.14834. Epub 2024 May 15. ESC Heart Fail. 2024. PMID: 38751135 Free PMC article.
-
Cardiopulmonary exercise testing and heart failure: a tale born from oxygen uptake.Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C319-C325. doi: 10.1093/eurheartjsupp/suad057. eCollection 2023 May. Eur Heart J Suppl. 2023. PMID: 37125287 Free PMC article.
-
Risk classification for long-term mortality among patients with acute heart failure: China PEACE 4YMortality.ESC Heart Fail. 2025 Jun;12(3):1992-2009. doi: 10.1002/ehf2.15207. Epub 2025 Mar 17. ESC Heart Fail. 2025. PMID: 40091864 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous